Comparative effects of mesenchymal stromal cells of various origins and sources on biochemical parameters in the hippocampus of rats during cerebral ischemia-reperfusion

Home/2024, Vol. 12, No. 2/Comparative effects of mesenchymal stromal cells of various origins and sources on biochemical parameters in the hippocampus of rats during cerebral ischemia-reperfusion

Cell and Organ Transplantology. 2024; 12(2):118-125 (e2024122169).
DOI: 10.22494/cot.v12i2.169

Comparative effects of mesenchymal stromal cells of various origins and sources on biochemical parameters in the hippocampus of rats during cerebral ischemia-reperfusion

Konovalov S.1, Moroz V.1, Yoltukhivskyi M.1, Gadzhula N.1, Deryabina O.2,3, Kordium V.2,3

  • 1National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • 2Institute of Genetic and Regenerative Medicine, M. D. Strazhesko National Scientific Center of Cardiology, Clinical and Regenerative Medicine, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine Kyiv, Ukraine
  • 3Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv, Ukraine

Abstract

In neurodegenerative processes of the brain, the hippocampus is primarily affected, leading to subsequent cognitive impairments caused by increased generation of reactive oxygen and nitrogen species. These reactive species induce apoptosis and necrosis of neurons. Cell therapy using mesenchymal stromal cells (MSCs) has shown promising potential in activating endogenous mechanisms of neuroregeneration in response to ischemic injury of brain structures.
The purpose of this study is to investigate the therapeutic potential of MSCs from various origins, MSC lysate, and the reference drug citicoline on the energy component of neuronal metabolism, as well as oxidative and nitrosative stress in the rat hippocampus under conditions of cerebral ischemia-reperfusion (IR).
Material and methods. The experiment was conducted on 126 Wistar rats with a modeled pathology (20-minute IR of the internal carotid arteries). The animals were injected with human umbilical cord Wharton’s jelly-derived MSCs, human and rat adipose-derived MSCs, rat embryonic fibroblasts, MSC lysate, or citicoline immediately after the removal of the ligatures. Biochemical parameters of carbohydrate metabolism (glucose, lactate), oxidative (NADPH oxidase activity) and nitrosative stress (NO synthase activity) in the rat hippocampus were determined on days 7 and 14 after IR under the conditions of cerebral IR and on the background of its correction.
Results. It was established that during ischemia-reperfusion in the rat hippocampus, glucose and lactate levels increase, aerobic glucose oxidation is inhibited, anaerobic glycolysis intensifies, and lactic acidosis develops in hippocampal cells. Additionally, NADPH oxidase activity decreases, and an imbalance occurs in the nitric oxide system. A positive effect was observed from the transplantation of human umbilical cord Wharton’s jelly-derived MSCs and rat embryonic fibroblasts, as well as from the use of citicoline, in stabilizing glucose, lactate, NADPH oxidase, and nitric oxide levels. In contrast, the transplantation of human and rat adipose-derived MSCs was significantly less effective than citicoline and demonstrated no statistically significant modulatory effect on biochemical parameters in the hippocampus of experimental animals with IR.
Conclusions. Transplantation of human umbilical cord Wharton’s jelly-derived MSCs was not inferior to citicoline and, compared to other tested MSCs and their lysate, more effectively contributed to the recovery of disturbed energy processes (glucose levels) and the elimination of metabolic acidosis (lactate levels) in the hippocampus of rats. Moreover, it demonstrated a positive modulatory effect on the oxidant-antioxidant balance, as indicated by NADPH oxidase activity levels.

Keywords: mesenchymal stromal cells; hippocampus; cerebral ischemia-reperfusion injury; carbohydrate metabolism; oxidative stress


Full text PDF

1. Akinyemi RO, Norrving B, Brainin M, Feigin VL. Stroke Experts Collaboration Group Primary stroke prevention worldwide: translating evidence into action. The Lancet. Public health. 2022; 7(1), e74-e85.
https://doi.org/10.1016/S2468-2667(21)00230-9
PMid:34756176
2. Andrabi SS, Parvez S, Tabassum H. Ischemic stroke and mitochondria: mechanisms and targets. Protoplasma. 2020; 257(2):335-343.
https://doi.org/10.1007/s00709-019-01439-2
PMid:31612315
3. Arnberg F, Grafström J, Lundberg J, Nikkhou-Aski S, Little P, Damberg P, et al. Imaging of a clinically relevant stroke model: glucose hypermetabolism revisited. Stroke. 2015; 46(3):835-842.
https://doi.org/10.1161/STROKEAHA.114.008407
PMid:25657187
4. Brooks B, Ebedes D, Usmani A, Gonzales-Portillo JV, Gonzales-Portillo D, Borlongan CV. Mesenchymal Stromal Cells in Ischemic Brain Injury. Cells. 2022; 11(6):1013.
https://doi.org/10.3390/cells11061013
PMid:35326464 PMCid:PMC8947674
5. Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, et al. Ischaemic stroke. Nature reviews. Disease primers. 2019; 5(1):70.
https://doi.org/10.1038/s41572-019-0118-8
PMid:31601801
6. Chavda V, Chaurasia B, Garg K, Deora H, Umana GE, Palmisciano P, et al. Molecular mechanisms of oxidative stress in stroke and cancer. Brain Disord. 2022; 5:100029.
https://doi.org/10.1016/j.dscb.2021.100029
7. Chen Y, Peng D, Li J, Zhang L, Chen J, Wang L, et al. A comparative study of different doses of bone marrow-derived mesenchymal stem cells improve post-stroke neurological outcomes via intravenous transplantation. Brain research. 2023; 1798:148161.
https://doi.org/10.1016/j.brainres.2022.148161
PMid:36379315
8. Chen Y, Qin C, Huang J, Tang X, Liu C, Huang K, et al. The role of astrocytes in oxidative stress of central nervous system: A mixed blessing. Cell proliferation. 2020; 53(3):e12781.
https://doi.org/10.1111/cpr.12781
PMid:32035016 PMCid:PMC7106951
9. Chung JW, Chang WH, Bang OY, Moon GJ, Kim SJ, Kim SK, et al. Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke. Neurology. 2021; 96(7):e1012-e1023.
https://doi.org/10.1212/WNL.0000000000011440
PMCid:PMC8205458
10. Cui LL, Golubczyk D, Tolppanen AM, Boltze J, Jolkkonen J. Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Ann Neurol. 2019; 86(1):5-16.
https://doi.org/10.1002/ana.25493
PMid:31020699
11. Galipeau J, Sensébé L. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell stem cell. 2018; 22(6):824-833.
https://doi.org/10.1016/j.stem.2018.05.004
PMid:29859173 PMCid:PMC6434696
12. Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer GMitochondrial control of cellular life, stress, and death. Circulation research. 2012; 111(9):1198-1207.
https://doi.org/10.1161/CIRCRESAHA.112.268946
PMid:23065343
13. García-Sánchez A, Miranda-Díaz AG, Cardona-Muñoz EG. The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases. Oxidative medicine and cellular longevity. 2020; 2082145.
https://doi.org/10.1155/2020/2082145
PMid:32774665 PMCid:PMC7396016
14. GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. Neurology, (2019)18(5), 459-480.
https://doi.org/10.1016/S1474-4422(18)30499-X
PMid:30879893
15. Grossberg JA, Rebello LC, Haussen DC, Bouslama M, Bowen M, Barreira CM, et al. Beyond Large Vessel Occlusion Strokes: Distal Occlusion Thrombectomy. Stroke. 2018; 49(7):1662-1668.
https://doi.org/10.1161/STROKEAHA.118.020567
PMid:29915125
16. Gula NM, Kosyakova GV, Berdyshev AG. The effect of N-stearoylethanolamine on the NO-synthase pathway of nitric oxide generation in the aorta and heart of rats with streptozotocin-induced diabetes. The Ukrainian Biochemical Journal. 2007; 79(5):153-158.
17. He Z, Ning N, Zhou Q, Khoshnam SE, Farzaneh M. Mitochondria as a therapeutic target for ischemic stroke. Free Radic Biol Med. 2020; 146:45-58.
https://doi.org/10.1016/j.freeradbiomed.2019.11.005
PMid:31704373
18. Higashi Y, Aratake T, Shimizu T, Shimizu S, Saito M. Protective Role of Glutathione in the Hippocampus after Brain Ischemia. International journal of molecular sciences. 2021; 22(15):7765.
https://doi.org/10.3390/ijms22157765
PMid:34360532 PMCid:PMC8345998
19. Inderhees J, Schwaninger M. Liver Metabolism in Ischemic Stroke. Neuroscience. 2024; 550:62-68.
https://doi.org/10.1016/j.neuroscience.2023.12.013
PMid:38176607
20. Jacobs LC, Arntz RM, Schoonderwaldt HC, Dorresteijn LD, de Leeuw FE, Kessels RP. Ipsilateral hippocampal atrophy is associated with long-term memory dysfunction after ischemic stroke in young adults. Human brain mapping. 2015; 36(7):2432-2442.
https://doi.org/10.1002/hbm.22782
PMid:25757914 PMCid:PMC6869088
21. Jadhav AP, Desai SM, Kenmuir CL, Rocha M, Starr MT, Molyneaux BJ, et al. Eligibility for Endovascular Trial Enrollment in the 6- to 24-Hour Time Window: Analysis of a Single Comprehensive Stroke Center. Stroke. 2018; 49(4):1015-1017.
https://doi.org/10.1161/STROKEAHA.117.020273
PMid:29581344
22. Konovalov S, Moroz V, Konovalova N, Deryabina O, Shuvalova N, Toporova O, et al. The effect of mesenchymal stromal cells of various origins on mortality and neurologic deficit in acute cerebral ischemia-reperfusion in rats. Cell Organ Transplant. 2021; 9(2):104-108.
https://doi.org/10.22494/cot.v9i2.132
23. Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. International journal of molecular sciences. 2020; 21(20):7609.
https://doi.org/10.3390/ijms21207609
PMid:33076218 PMCid:PMC7589849
24. Li J, Zhang Q, Wang W, Lin F, Wang S, Zhao J. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential. Journal of neurology. 2021; 268(11):4095-4107.
https://doi.org/10.1007/s00415-020-10138-5
PMid:32761505
25. Liau LL, Ruszymah BHI, Ng MH, Law JX. Characteristics and clinical applications of Wharton’s jelly-derived mesenchymal stromal cells. Current research in translational medicine. 2020; 68(1):5-16.
https://doi.org/10.1016/j.retram.2019.09.001
PMid:31543433
26. Liu, L., Kearns, K. N., Eli, I., Sharifi, K. A., Soldozy, S., Carlson, E. W., Scott, K. W., Sluzewski, M. F., Acton, S. T., Stauderman, K. A., Kalani, M. Y. S., Park, M., & Tvrdik, P. (2021). Microglial Calcium Waves During the Hyperacute Phase of Ischemic Stroke. Stroke, 52(1), 274-283.
https://doi.org/10.1161/STROKEAHA.120.032766
PMid:33161850 PMCid:PMC7770090
27. Martynov MY, Zhuravleva MV, Vasyukova NS, Kuznetsova EV, Kameneva TR. Oxidative stress in the pathogenesis of stroke and its correction. Zhurnal nevrologii i psikhiatrii imeni S. S. Korsakova. 2023; 123(1):16-27.
https://doi.org/10.17116/jnevro202312301116
PMid:36719115
28. Murphy MP, Hartley RC. Mitochondria as a therapeutic target for common pathologies. Nature reviews. Drug discovery. 2018; 17(12):865-886.
https://doi.org/10.1038/nrd.2018.174
PMid:30393373
29. Musuka TD, Wilton SB, Traboulsi M, Hill MD. Diagnosis and management of acute ischemic stroke: speed is critical. CMAJ. 2015; 187(12):887-893.
https://doi.org/10.1503/cmaj.140355
PMid:26243819 PMCid:PMC4562827
30. Ntege EH, Sunami H, Shimizu Y. Advances in regenerative therapy: A review of the literature and future directions. Regenerative therapy. 2020; 14:136-153.
https://doi.org/10.1016/j.reth.2020.01.004
PMid:32110683 PMCid:PMC7033303
31. Oh SH, Choi C, Noh JE, Lee N, Jeong YW, Jeon I, et al. Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke model. Exp Mol Med. 2018; 50(4):1-12.
https://doi.org/10.1038/s12276-018-0041-1
PMid:29650950 PMCid:PMC5938060
32. Olufunmilayo EO, Gerke-Duncan MB, Holsinger RMD. Oxidative Stress and Antioxidants in Neurodegenerative Disorders. Antioxidants (Basel, Switzerland). 2023; 12(2):517.
https://doi.org/10.3390/antiox12020517
PMid:36830075 PMCid:PMC9952099
33. Owolabi MO, Thrift AG, Mahal A, Ishida M, Martins S, Johnson WD, et al. Primary stroke prevention worldwide: translating evidence into action. The Lancet. Public health. 2022; 7(1):e74-e85.
https://doi.org/10.1016/S2468-2667(21)00230-9
PMid:34756176
34. Pérez-Corredor PA, Gutiérrez-Vargas JA, Ciro-Ramírez L, Balcazar N, Cardona-Gómez GP. High fructose diet-induced obesity worsens post-ischemic brain injury in the hippocampus of female rats. Nutritional neuroscience. 2022; 25(1):122-136.
https://doi.org/10.1080/1028415X.2020.1724453
PMid:32116157
35. Semenova E, Grudniak MP, Machaj EK, Bocian K, Chroscinska-Krawczyk M, Trochonowicz M, et al. Mesenchymal Stromal Cells from Different Parts of Umbilical Cord: Approach to Comparison & Characteristics. Stem cell reviews and reports. 2021; 17(5):1780-1795.
https://doi.org/10.1007/s12015-021-10157-3
PMid:33860454 PMCid:PMC8553697
36. Simão F, Ustunkaya T, Clermont AC, Feener EP. Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke. Blood. 2017; 129(16):2280-2290.
https://doi.org/10.1182/blood-2016-09-740670
PMid:28130211 PMCid:PMC5399481
37. Song K, Li Y, Zhang H, An N, Wei Y, Wang L, et al. Oxidative stress-mediated blood-brain barrier (BBB) disruption in neurological diseases. Oxid Med Cell Longev. 2020.
https://doi.org/10.1155/2020/4356386
38. Stroncek DF, Jin P, McKenna DH, Takanashi M, Fontaine MJ, Pati S, et al. Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Front Cell Dev Biol. 2020; 8:458.
https://doi.org/10.3389/fcell.2020.00458
PMid:32612991 PMCid:PMC7308721
39. Tao J, Chen B, Gao Y, Yang S, Huang J, Jiang X, et al. Electroacupuncture enhances hippocampal NSCs proliferation in cerebral ischemia-reperfusion injured rats via activation of notch signaling pathway. The International journal of neuroscience. 2014; 124(3):204-212.
https://doi.org/10.3109/00207454.2013.840781
PMid:24004240
40. Wang F, Tang H, Zhu J, Zhang JH. Transplanting mesenchymal stem cells for treatment of ischemic stroke. Cell transplantation. 2018; 27(12):1825-1834.
https://doi.org/10.1177/0963689718795424
PMid:30251564 PMCid:PMC6300770
41. Wu X, Jiang J, Gu Z, Zhang J, Chen Y, Liu X. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress. Stem Cell Res Ther. 2020; 11(1):345.
https://doi.org/10.1186/s13287-020-01855-9
PMid:32771052 PMCid:PMC7414268
42. Zhao SC, Ma LS, Chu ZH, Xu H, Wu WQ, Liu F. Regulation of microglial activation in stroke. Acta pharmacologica Sinica. 2017; 38(4):445-458.
https://doi.org/10.1038/aps.2016.162
PMid:28260801 PMCid:PMC5386316

Konovalov S, Moroz V, Yoltukhivskyi M, Gadzhula N, Deryabina O, Kordium V. Comparative effects of mesenchymal stromal cells of various origins and sources on biochemical parameters in the hippocampus of rats during cerebral ischemia-reperfusion. Cell Organ Transpl. 2024; 12(2):118-125 (e2024122169). doi: https://doi.org/10.22494/cot.v12i2.169

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.